TABLE 1.
Comparison of the mortality and surviving groups in terms of various parameters
| n = 388 | Surviving (n = 264) | Mortality (n = 124) | P value | |
|---|---|---|---|---|
| Gender F/M (%) | 123/141 (46.6/53.4) | 45/79 (36.3/63.7) | ||
| Age, years | Mean ± SD | 69 ± 15 | 72 ± 15 | .182 |
| Procalcitonin µg/L | Median (percentile 25‐75) | 0.14 (0.04‐0.52) | 0.35 (0.17‐1.36) | .243 |
| DNI% | Median (percentile 25‐75) | 0.10 (0.10‐0.55) | 1.00 (0.10‐2.60) | .003 |
| Leukocyte × 106/L | Median (percentile 25‐75) | 8430 (6015‐12 255) | 9365 (6755‐12 640) | .498 |
| Platelet × 109/L | Median (percentile 25‐75) | 250 (179‐318) | 235 (141‐315) | .058 |
| Lymphocyte × 109/L | Median (percentile 25‐75) | 0.90 (0.60‐1.41) | 0.77 (0.50‐1.14) | .024 |
| Neutrophil/lymphocyte ratio | Median (percentile 25‐75) | 7.47 (3.92‐13.01) | 9.36 (5.93‐15.90) | .034 |
| RDW% | Mean ± SD | 15.40 ± 2.49 | 15.87 ± 2.17 | .075 |
| Lactate | Median (percentile 25‐75) | 1.68 (1.25‐2.21) | 2.15 (1.52‐3.09) | .000 |
| Interleukin‐6 pg/mL | Median (percentile 25‐75) | 46.10 (23.70‐92.00) | 94.20 (46.20‐239.00) | .002 |
| CRP mg/L | Median (percentile 25‐75) | 65 (26‐129) | 119 (60‐185) | .000 |
| COVID‐19 PCR | Negative | 159 (60.2%) | 58 (46.8%) | .014 |
| Positive | 105 (39.8%) | 66 (53.2%) | ||
| Chest CT (COVID‐19 suspicion) | Negative | 22 (8.3%) | 5 (4%) | .081 |
| Positive | 242 (91.7%) | 119 (96%) | ||
| Number of hospitalised days | Median (percentile 25‐75) | 8 (5‐13) | 5 (3‐11) | .027 |
Abbreviations: COVID‐19, Coronavirus‐19; CRP, C‐reactive protein; CT, computed tomography; DNI, delta neutrophil index; PCR, polymerase chain reaction; SD, standard deviation.
P values written in bold show statistically significance.